Fresenius Medical Care AG & Co. PT Lowered to $33.00 (FMS)
Research analysts at Piper Jaffray cut their price objective on shares of Fresenius Medical Care AG & Co. (NYSE:FMS) from $34.00 to $33.00 in a report released on Monday, Analyst Ratings News reports. Piper Jaffray’s price target indicates a potential upside of 0.82% from the company’s current price.
FMS has been the subject of a number of other recent research reports. Analysts at Zacks downgraded shares of Fresenius Medical Care AG & Co. from a “neutral” rating to an “underperform” rating in a research note on Wednesday, April 23rd. They now have a $32.40 price target on the stock. Separately, analysts at Berenberg Bank downgraded shares of Fresenius Medical Care AG & Co. from a “buy” rating to a “hold” rating in a research note on Wednesday, March 5th. Finally, analysts at HSBC downgraded shares of Fresenius Medical Care AG & Co. from a “neutral” rating to an “underweight” rating in a research note on Tuesday, March 4th. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $36.10.
Fresenius Medical Care AG & Co. (NYSE:FMS) opened at 32.73 on Monday. Fresenius Medical Care AG & Co. has a one year low of $30.75 and a one year high of $37.01. The stock has a 50-day moving average of $34.12 and a 200-day moving average of $34.43. The company has a market cap of $19.740 billion and a P/E ratio of 18.09.
Fresenius Medical Care AG & Co. (NYSE:FMS) last released its earnings data on Wednesday, May 7th. The company reported $0.34 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.38 by $0.04. Analysts expect that Fresenius Medical Care AG & Co. will post $1.70 EPS for the current fiscal year.
The company also recently declared a annual dividend, which is scheduled for Tuesday, May 27th. Investors of record on Thursday, May 15th will be given a dividend of $0.5335 per share. This represents a yield of 1.57%. The ex-dividend date of this dividend is Tuesday, May 13th.
Fresenius Medical Care AG & Co KGaA is a Germany-based holding and kidney dialysis company, operating in the fields of dialysis products and dialysis services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.